Skip to main content

C V Starr & Co Inc

13F filer · CIK 0001340459
Reported Aug 11, 2026
13F portfolio value$187MU.S. long equity reported on 13F
Positions30 new · 0 closed
Net flow last quarter$0Buys minus sells
Top 10 positions weight68.3%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 11, 20263 positions
GLDSPDR Gold Trust$92.6M49.45%0.07%Not reportedQ4 2024
IDEVEndo Pharmaceuticals Solutions Inc.$33.7M18.00%Not reportedNot reportedQ2 2025
CELUCelularity Inc$1.58M0.84%2.64%Not reportedQ4 2021
Q1 2026Reported May 11, 20263 positions
GLDSPDR Gold Trust$108M56.41%0.07%Not reportedQ4 2024
IDEVEndo Pharmaceuticals Solutions Inc.$31.7M16.51%Not reportedNot reportedQ2 2025
CELUCelularity Inc$1.02M0.53%2.65%Not reportedQ4 2021
Q4 2025Reported Feb 9, 20263 positions
GLDSPDR Gold Trust$99.6M54.75%0.07%-34.1%Q4 2024
IDEVEndo Pharmaceuticals Solutions Inc.$31.2M17.17%Not reportedNot reportedQ2 2025
CELUCelularity Inc$1.58M0.87%2.65%Not reportedQ4 2021
Q3 2025Reported Nov 12, 20253 positions
GLDSPDR Gold Trust$136M62.66%0.11%Not reportedQ4 2024
IDEVEndo Pharmaceuticals Solutions Inc.$30.4M14.02%Not reportedNot reportedQ2 2025
CELUCelularity Inc$1.58M0.73%2.71%Not reportedQ4 2021
Premium opens every quarter this fund has filed
SpoorBase

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.